Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA): description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
Haplotype: haplotype on which variant was found
RNA change: description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method: The method used for the clinical classification of this variant.
All options:
- ACMG
- ACGS
- EAHAD-CFDB
- ENIGMA
- IARC
- InSiGHT
- kConFab
- other
Clinical classification: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
- pathogenic
- pathogenic (dominant)
- pathogenic (recessive)
- pathogenic (!)
- pathogenic (maternal)
- pathogenic (paternal)
- likely pathogenic
- likely pathogenic (dominant)
- likely pathogenic (recessive)
- likely pathogenic (!)
- likely pathogenic (maternal)
- likely pathogenic (paternal)
- VUS
- VUS (!)
- likely benign
- likely benign (dominant)
- likely benign (recessive)
- likely benign (!)
- likely benign (maternal)
- likely benign (paternal)
- benign
- benign (dominant)
- benign (recessive)
- benign (!)
- benign (maternal)
- benign (paternal)
- conflicting
- association
- NA
DNA change (genomic) (hg19): HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38): HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN: description of the variant according to ISCN nomenclature
DB-ID: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID: ID of variant in ClinVar database
dbSNP ID: the dbSNP ID
Origin: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
- Germline
- De novo
- Germline/De novo (untested)
- Somatic
- Uniparental disomy
- Uniparental disomy, maternal allele
- Uniparental disomy, paternal allele
- CLASSIFICATION record
- SUMMARY record
- In vitro (cloned)
- In silico
- animal model
- Artefact
- DUPLICATE record
- Unknown
- Not applicable
Segregation: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
- ? = unknown
- yes = segregates with phenotype
- no = does not segregate with phenotype
- - = not applicable
Frequency: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Methylation: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)

 Effect
|

 Exon
|

 DNA change (cDNA)
|

 Haplotype
|

 RNA change
|

 Protein
|

 Classification method
|

 Clinical classification
|

 DNA change (genomic) (hg19)
|

 DNA change (hg38)
|

 Published as
|

 ISCN
|

 DB-ID
|
 Variant remarks
|

 Reference
|

 ClinVar ID
|

 dbSNP ID
|

 Origin
|

 Segregation
|

 Frequency
|

 Re-site
|

 VIP
|

 Methylation
|

 Owner
|
+?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
likely pathogenic (recessive) |
g.155271256T>G |
g.155301465T>G |
c.-70A>C |
- |
PKLR_000062 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
pathogenic (recessive) |
g.155271435del |
g.155301644del |
c.-249delA |
- |
PKLR_000062 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
pathogenic (recessive) |
g.155271435del |
g.155301644del |
c.-249delA |
- |
PKLR_000062 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
likely pathogenic (recessive) |
g.155271269C>G |
g.155301478C>G |
c.-83G>C |
- |
PKLR_000076 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
pathogenic (recessive) |
g.155271435del |
g.155301644del |
c.-249delA |
- |
PKLR_000062 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
NA |
g.155271277A>T |
g.155301486A>T |
c.-91T>A |
- |
PKLR_000062 |
in vitro expression K562 cells shows normal promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
NA |
g.155271276G>A |
g.155301485G>A |
c.-90C>T |
- |
PKLR_000062 |
in vitro expression K562 cells shows normal promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|inc |
p.=|inc |
- |
NA |
g.155271275A>C |
g.155301484A>C |
c.-89T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows increased promoter activity (1.3) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|inc |
p.=|inc |
- |
NA |
g.155271274A>C |
g.155301483A>C |
c.-88T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows increased promoter activity (1.5) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271273G>T |
g.155301482G>T |
c.-87C>A |
- |
PKLR_000062 |
in vitro expression K562 cells shows significantly reduced promoter activity (0.5) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271272A>C |
g.155301481A>C |
c.-86T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows significantly reduced promoter activity (0.3) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271271G>T |
g.155301480G>T |
c.-85C>A |
- |
PKLR_000062 |
in vitro expression K562 cells shows significantly reduced promoter activity (0.3) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271270A>C |
g.155301479A>C |
c.-84T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows significantly reduced promoter activity (0.1) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
NA |
g.155271268A>C |
g.155301477A>C |
c.-82T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows normal promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271267G>T |
g.155301476G>T |
c.-81C>A |
- |
PKLR_000062 |
in vitro expression K562 cells shows reduced promoter activity (0.8) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|inc |
p.=|inc |
- |
NA |
g.155271266A>C |
g.155301475A>C |
c.-80T>G |
- |
PKLR_000062 |
in vitro expression K562 cells shows increased promoter activity (1.3) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271265G>A |
g.155301474G>A |
c.-79C>T |
- |
PKLR_000062 |
in vitro expression K562 cells shows reduced promoter activity (0.7) |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
NA |
g.155271264G>A |
g.155301473G>A |
c.-78C>T |
- |
PKLR_000062 |
in vitro expression K562 cells shows normal promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
likely benign |
g.155271691del |
g.155301900del |
c.-503del |
- |
PKLR_000062 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
likely benign |
g.155271550A>G |
g.155301759A>G |
c.-364T>C |
- |
PKLR_000062 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
11i_12_ |
c.(1618+1_1619-1)_*1279{0} |
- |
r.? |
p.? |
- |
pathogenic (recessive) |
g.(?_155259084)_(155260470_155261546)del |
g.(?_155289293)_(155290679_155291755)del |
del ex11 |
- |
PKLR_000311 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
11i_12_ |
c.(1618+1_1619-1)_*1279{0} |
- |
r.? |
p.? |
- |
pathogenic (recessive) |
g.(?_155259084)_(155260470_155261546)del |
g.(?_155289293)_(155290679_155291755)del |
del ex11 |
- |
PKLR_000311 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.(c.-39_*1279)del |
- |
r.? |
p.? |
- |
pathogenic (recessive) |
g.(?_155259084)_(155271225_?)del |
g.(?_155289293)_(155301434_?)del |
large deletion |
- |
PKLR_000312 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.-156G>C |
- |
r.(?) |
p.(=) |
- |
pathogenic |
g.155271342C>G |
g.155301551C>G |
- |
- |
PKLR_000244 |
erythroid-specific promoter |
Manco and Ribeiro, unpublished |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
-/. |
- |
c.-148C>T |
- |
r.(?) |
p.(=) |
- |
benign |
g.155271334G>A |
g.155301543G>A |
PKLR(NM_000298.6):c.-148C>T |
- |
PKLR_000299 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
-?/. |
- |
c.-117G>T |
- |
r.(?) |
p.(=) |
- |
likely benign |
g.155271303C>A |
g.155301512C>A |
PKLR(NM_000298.6):c.-117G>T |
- |
PKLR_000298 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
+/. |
- |
c.-82G>C |
- |
r.(?) |
p.(=) |
- |
pathogenic |
g.155271268C>G |
- |
- |
- |
PKLR_000243 |
PK type Hamburg
Variant Error [EREF/ERANGE]: This genomic variant does not match the reference sequence; the transcript variant also has an error. Please fix this entry and then remove this message. |
Kugler 2002 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
- |
c.-71A>G |
- |
r.(?) |
p.(=) |
- |
pathogenic |
g.155271257T>C |
- |
-72A>G |
- |
PKLR_000135 |
Variant Error [EREF/ERANGE]: This genomic variant does not match the reference sequence; the transcript variant also has an error. Please fix this entry and then remove this message. |
PubMed: Coutinho et al. 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
-?/. |
_1 |
- |
- |
r.0 |
p.0 |
- |
likely benign |
g.155271510A>T |
g.155301719A>T |
-324T>A |
- |
PKLR_000075 |
not in 100 control chromosomes; allele not detecably expressed |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
- |
BstXI |
- |
- |
Richard van Wijk |
?/. |
_1 |
- |
- |
r.(=) |
p.(=) |
- |
likely benign |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
since the individuals are not affected, variant suggested not to be deleterious |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
?/. |
_1 |
- |
- |
r.0 |
p.0 |
- |
benign (!) |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
allele not detectably expressed |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
-?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
likely benign |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
34/241 heterozygous control |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
34/241 controls |
- |
- |
- |
Richard van Wijk |
-?/. |
_1 |
- |
- |
r.(?) |
p.(?) |
- |
likely benign |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
- |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
1/241 controls |
- |
- |
- |
Richard van Wijk |
?/. |
_1 |
- |
- |
r.(?) |
p.(?) |
- |
VUS |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
Van Wijk wonders whther variant is described correctly |
PubMed: Pissard 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
VUS |
g.155271295G>A |
- |
-109C>T |
- |
PKLR_000132 |
Van Wijk wonders whether variant -148C>T is meant; no variant 2nd chromosome |
PubMed: Pissard 2006, PubMed: Van Wijk 2007 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.0 |
p.0 |
- |
pathogenic (recessive) |
g.155271269C>G |
g.155301478C>G |
-83G>C |
- |
PKLR_000076 |
not in 100 control chromosomes; allele not detecably expressed |
PubMed: Van Wijk 2003 |
- |
- |
Germline |
- |
- |
BsmAI |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
pathogenic (recessive) |
g.155271259C>G |
g.155301468C>G |
-73G>C |
- |
PKLR_000201 |
variant affects erythroid-specific promoter |
PubMed: Marcello 2008 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
pathogenic |
g.155271258T>C |
g.155301467T>C |
-72A>G |
- |
PKLR_000062 |
erythroid-specific promoter varaint, reduced mRNA levels (0.2); not in 100 control chromosomes |
PubMed: Manco 2000 |
- |
- |
Germline |
- |
- |
Bsu36I+ |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
pathogenic (recessive) |
g.155271258T>C |
g.155301467T>C |
-72A>G |
- |
PKLR_000062 |
erythroid-specific promoter varaint, reduced mRNA levels (0.2); not in 100 control chromosomes |
PubMed: Manco 2000 |
- |
- |
Germline |
- |
- |
Bsu36I+ |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
pathogenic (recessive) |
g.155271258T>C |
g.155301467T>C |
-72A>G |
- |
PKLR_000062 |
erythroid-specific promoter varaint, reduced mRNA levels (0.2); not in 100 control chromosomes |
PubMed: Manco 2000 |
- |
- |
Germline |
- |
- |
Bsu36I+ |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
pathogenic (recessive) |
g.155271258T>C |
g.155301467T>C |
-72A>G |
- |
PKLR_000062 |
erythroid-specific promoter varaint, reduced mRNA levels (0.2); not in 100 control chromosomes |
PubMed: Manco 2000 |
- |
- |
Germline |
- |
- |
Bsu36I+ |
- |
- |
Richard van Wijk |
+?/. |
_1 |
- |
- |
r.=|inc |
p.=|inc |
- |
NA |
g.155271434del |
g.155301643del |
-248delT |
- |
PKLR_000074 |
in vitro expression K562 cells shows significant increased promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
NA |
g.155271269C>G |
g.155301478C>G |
-83G>C |
- |
PKLR_000076 |
in vitro expression K562 cells shows significantly reduced promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Richard van Wijk |
-/. |
_1 |
- |
- |
r.= |
p.= |
- |
NA |
g.155271510A>T |
- |
-324T>A |
- |
PKLR_000062 |
in vitro expression K562 cells shows normal promoter activity |
PubMed: Van Wijk 2003 |
- |
- |
In vitro (cloned) |
- |
- |
- |
- |
- |
Johan den Dunnen |
?/. |
_1 |
- |
- |
r.(?) |
p.(=) |
- |
VUS |
g.155271334G>A |
- |
-148T |
- |
PKLR_000062 |
- |
PubMed: Manco 2001 |
- |
- |
Germline |
- |
0.017 controls |
- |
- |
- |
Johan den Dunnen |
+/. |
_1 |
- |
- |
r.=|red |
p.=|red |
- |
pathogenic (recessive) |
g.155271444del |
.155301653del |
-249delA |
- |
PKLR_000062 |
severely reduced mRNA expression (0.06) |
PubMed: Kugler 1999 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-/- |
11i |
c.= |
- |
r.(=) |
p.(=) |
- |
benign |
g.? |
- |
c.1619-361ATT[17] |
- |
PKLR_000041 |
- |
PubMed: Baronciani and Beutler, 1995 |
- |
- |
Germline |
- |
3/100 |
- |
- |
- |
Richard van Wijk |
?/. |
- |
c.92C>T |
- |
r.(?) |
p.(Ala31Val) |
- |
VUS |
g.155271095G>A |
- |
PKLR(NM_000298.6):c.92C>T (p.A31V, p.(Ala31Val)) |
- |
HCN3_000006 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+?/. |
1 |
c.92C>T |
- |
r.(?) |
p.(Ala31Val) |
- |
likely pathogenic (recessive) |
g.155271095G>A |
g.155301304G>A |
- |
- |
HCN3_000006 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
?/. |
- |
c.92C>T |
- |
r.(?) |
p.(Ala31Val) |
- |
VUS |
g.155271095G>A |
g.155301304G>A |
- |
- |
HCN3_000006 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
?/. |
- |
c.92C>T |
- |
r.(?) |
p.(Ala31Val) |
- |
VUS |
g.155271095G>A |
- |
PKLR(NM_000298.6):c.92C>T (p.A31V, p.(Ala31Val)) |
- |
HCN3_000006 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+/. |
1i |
c.100+10G>A |
- |
r.spl |
p.? |
- |
pathogenic |
g.155271077C>T |
g.155301286C>T |
- |
- |
PKLR_000130 |
no variant 2nd chromosome |
PubMed: Pissard 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
1i |
c.100+10G>A |
- |
r.spl |
p.? |
- |
pathogenic |
g.155271077C>T |
g.155301286C>T |
- |
- |
PKLR_000130 |
no variant 2nd chromosome |
PubMed: Pissard 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
1i |
c.100+10G>T |
- |
r.spl |
p.? |
- |
pathogenic |
g.155271077C>A |
g.155301286C>A |
- |
- |
PKLR_000128 |
no variant 2nd chromosome |
PubMed: Pissard 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+?/. |
1i_3i |
c.(100+1_100+343)_(100+412_101-1)del |
- |
r.? |
p.? |
- |
likely pathogenic (recessive) |
g.(155270072_155270675)_(155270744_155271086)del |
g.(155300281_155300884)_(155300953_155301295)del |
del ex2 |
- |
PKLR_000361 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.101-327T>C |
- |
r.(?) |
p.? |
- |
likely benign |
g.155270398A>G |
g.155300607A>G |
- |
- |
PKLR_000421 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.101-325C>T |
- |
r.(?) |
p.? |
- |
likely benign |
g.155270396G>A |
g.155300605G>A |
- |
- |
PKLR_000420 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.101-201C>T |
- |
r.(?) |
p.? |
- |
likely benign |
g.155270272G>A |
g.155300481G>A |
- |
- |
PKLR_000419 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.101-119del |
- |
r.(?) |
p.? |
- |
likely benign |
g.155270193del |
g.155300402del |
- |
- |
PKLR_000418 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
2i |
c.101-1G>A |
- |
r.spl |
p.? |
- |
pathogenic (recessive) |
g.155270072C>T |
g.155300281C>T |
IVSA-1G>A |
- |
PKLR_000165 |
- |
PubMed: Lenzner 1994, PubMed: Lenzner 1997 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
- |
c.101-1G>A |
- |
r.spl |
p.? |
- |
pathogenic (recessive) |
g.155270072C>T |
- |
- |
- |
PKLR_000165 |
- |
PubMed: Lenzner 1994, PubMed: Lenzner 1997 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.107C>G |
- |
r.(?) |
p.(Ala36Gly) |
- |
pathogenic (recessive) |
g.155270065G>C |
g.155300274G>C |
- |
- |
PKLR_000001 |
no variant 2nd chromosome; HB, SH, UC |
PubMed: Fermo 2005 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
-?/. |
- |
c.108G>A |
- |
r.(?) |
p.(Ala36=) |
- |
likely benign |
g.155270064C>T |
g.155300273C>T |
- |
- |
PKLR_000417 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.109_130del |
- |
r.(?) |
p.(Gly37Trpfs*4) |
- |
pathogenic (recessive) |
g.155270043_155270064del |
- |
- |
- |
PKLR_000233 |
- |
PubMed: Manco 2008 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.110G>A |
- |
r.(?) |
p.(Gly37Glu) |
- |
benign (dominant) |
g.155270062C>T |
g.155300271C>T |
- |
- |
PKLR_000176 |
variant suggested to interfere with phosphorylation of Ser42, inhibiting PK enzymatic activity and accounting for increased enzymatic activity |
PubMed: Beutler 1997 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Richard van Wijk |
-?/. |
- |
c.111G>T |
- |
r.(?) |
p.(Gly37=) |
- |
likely benign |
g.155270061C>A |
- |
PKLR(NM_000298.6):c.111G>T (p.G37=) |
- |
HCN3_000009 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/. |
3 |
c.118C>T |
- |
r.(?) |
p.(Arg40Trp) |
- |
pathogenic (recessive) |
g.155270054G>A |
g.155300263G>A |
- |
- |
PKLR_000002 |
unknown variant 2nd chromosome |
PubMed: van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
?/. |
- |
c.119G>A |
- |
r.(?) |
p.(Arg40Gln) |
- |
VUS |
g.155270053C>T |
g.155300262C>T |
PKLR(NM_000298.6):c.119G>A (p.R40Q) |
- |
PKLR_000297 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
+/. |
3 |
c.119G>A |
- |
r.(?) |
p.(Arg40Gln) |
- |
pathogenic |
g.155270053C>T |
g.155300262C>T |
- |
- |
PKLR_000003 |
- |
{PMID:Van Wijk unpublished} |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.120del |
- |
r.(?) |
p.(Arg41GlyfsTer7) |
- |
pathogenic (recessive) |
g.155270053del |
g.155300262del |
c.119delG |
- |
PKLR_000360 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.129T>C |
- |
r.(?) |
p.(Ser43=) |
- |
likely benign |
g.155270043A>G |
- |
PKLR(NM_000298.6):c.129T>C (p.S43=) |
- |
HCN3_000008 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Rotterdam |
+/. |
3 |
c.142_159del |
- |
r.(?) |
p.(Thr48_Thr53del) |
- |
pathogenic (recessive) |
g.155270013_155270030del |
g.155300222_155300239del |
- |
- |
PKLR_000222 |
- |
PubMed: Van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
- |
c.142_159del |
- |
r.(?) |
p.(Thr48_Thr53del) |
- |
pathogenic (recessive) |
g.155270013_155270030del |
g.155300222_155300239del |
142_159del18 |
- |
PKLR_000222 |
- |
PubMed: Van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.142_159del |
- |
r.(?) |
p.(Thr48_Thr53del) |
- |
pathogenic (recessive) |
g.155270013_155270030del |
g.155300222_155300239del |
- |
- |
PKLR_000222 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/. |
3 |
c.143C>A |
- |
r.(?) |
p.(Thr48Asn) |
- |
likely pathogenic (recessive) |
g.155270029G>T |
g.155300238G>T |
- |
- |
PKLR_000359 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.171G>A |
- |
r.(?) |
p.(Gln57=) |
- |
likely benign |
g.155270001C>T |
g.155300210C>T |
- |
- |
PKLR_000416 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.172C>T |
- |
r.(?) |
p.(Gln58*) |
- |
pathogenic |
g.155270000G>A |
g.155300209G>A |
- |
- |
PKLR_000242 |
- |
Van Wijk unpublished |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.173_188dup |
Essen1 |
r.0 |
p.0 |
- |
pathogenic (recessive) |
g.155269989_155270004dup |
g.155300198_155300213dup |
183-184ins16bp |
- |
PKLR_000194 |
- |
PubMed: Kugler 2000 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
-?/. |
- |
c.181C>T |
- |
r.(?) |
p.(Leu61=) |
- |
likely benign |
g.155269991G>A |
g.155300200G>A |
PKLR(NM_000298.6):c.181C>T (p.L61=) |
- |
PKLR_000296 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
-?/. |
- |
c.181C>T |
- |
r.(?) |
p.(Leu61=) |
- |
likely benign |
g.155269991G>A |
g.155300200G>A |
- |
- |
PKLR_000296 |
- |
PubMed: Berghout 2012 |
- |
rs8177962 |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/. |
3 |
c.187G>A |
- |
r.(?) |
p.(Ala63Thr) |
- |
likely pathogenic (recessive) |
g.155269985C>T |
g.155300194C>T |
- |
- |
PKLR_000358 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+?/. |
3 |
c.194T>C |
- |
r.(?) |
p.(Met65Thr) |
- |
likely pathogenic (recessive) |
g.155269978A>G |
g.155300187A>G |
- |
- |
PKLR_000357 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
- |
c.218T>C |
- |
r.(?) |
p.(Leu73Pro) |
- |
pathogenic |
g.155269954A>G |
g.155300163A>G |
PKLR(NM_000298.6):c.218T>C (p.L73P) |
- |
PKLR_000295 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
+/. |
3 |
c.218T>C |
- |
r.(?) |
p.(Leu73Pro) |
- |
pathogenic (recessive) |
g.155269954A>G |
g.155300163A>G |
- |
- |
PKLR_000005 |
DS, SI(NA), {PKLR:73pro} |
PubMed: van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+?/. |
- |
c.224T>C |
- |
r.(?) |
p.(Leu75Pro) |
ACMG |
likely pathogenic (recessive) |
g.155269948A>G |
g.155300157A>G |
- |
- |
PKLR_000423 |
ACMG PM1, PM2, PP2, PP3 |
PubMed: Marinakis 2021 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Jan Traeger-Synodinos |
+/. |
3 |
c.227_231del |
- |
r.(?) |
p.(Leu76Hisfs*2) |
- |
pathogenic |
g.155269943_155269947del |
g.155300152_155300156del |
- |
- |
PKLR_000050 |
no variant 2nd chromosome |
PubMed: Zanella 1997 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
- |
c.227_231del |
- |
r.(?) |
p.(Leu76HisfsTer2) |
- |
pathogenic (recessive) |
g.155269943_155269947del |
g.155300152_155300156del |
del227-231 |
- |
PKLR_000050 |
- |
PubMed: Zanella 2007 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.238T>C |
- |
r.238u>c |
p.Ser80Pro |
- |
pathogenic (recessive) |
g.155269934A>G |
g.155300143A>G |
- |
- |
PKLR_000006 |
HB, SH, {PKLR:80pro} |
PubMed: Uenaka 1995 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.238T>C |
- |
r.(?) |
p.(Ser80Pro) |
- |
pathogenic (recessive) |
g.155269934A>G |
g.155300143A>G |
- |
- |
PKLR_000006 |
HB, SH, {PKLR:80pro} |
PubMed: Kugler 2000 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.245C>A |
- |
r.(?) |
p.(Pro82His) |
- |
pathogenic |
g.155269927G>T |
g.155300136G>T |
- |
- |
PKLR_000226 |
- |
PubMed: Finkenstedt 2008 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.245C>A |
- |
r.(?) |
p.(Pro82His) |
- |
pathogenic (recessive) |
g.155269927G>T |
g.155300136G>T |
- |
- |
PKLR_000226 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.246del |
- |
r.(?) |
p.(Val83Trpfs*25) |
- |
pathogenic (recessive) |
g.155269928del |
g.155300137del |
delC244 |
- |
PKLR_000089 |
- |
PubMed: Fermo 2005, PubMed: Zanella 2007 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.269T>A |
- |
r.(?) |
p.(Ile90Asn) |
- |
pathogenic (recessive) |
g.155269903A>T |
g.155300112A>T |
- |
- |
PKLR_000216 |
BH, SH, {PKLR:90asn} |
PubMed: Van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
- |
c.269T>A |
- |
r.(?) |
p.(Ile90Asn) |
- |
pathogenic (recessive) |
g.155269903A>T |
- |
- |
- |
PKLR_000216 |
- |
PubMed: Van Wijk 2009 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.269T>A |
- |
r.(?) |
p.(Ile90Asn) |
- |
pathogenic (recessive) |
g.155269903A>T |
g.155300112A>T |
- |
- |
PKLR_000216 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
+/. |
3 |
c.278C>T |
- |
r.(?) |
p.(Thr93Ile) |
- |
pathogenic (recessive) |
g.155269894G>A |
g.155300103G>A |
- |
- |
PKLR_000081 |
AS, HB, {PKLR:93ile} |
PubMed: Fermo 2005, PubMed: Zanella 2007 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.283G>A |
- |
RNA processing (IIc) |
p.(Gly95Arg) |
- |
pathogenic |
g.155269889C>T |
g.155300098C>T |
- |
- |
PKLR_000148 |
BH, NA, SH, {PKLR:95arg} |
Van Wijk 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.283G>A |
- |
r.101_283del |
p.Pro35_Gly95del |
- |
pathogenic |
g.155269889C>T |
g.155300098C>T |
- |
- |
PKLR_000240 |
PK type |
Van Wijk 2006 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Richard van Wijk |
+/. |
3 |
c.283G>A |
- |
r.spl? |
p.(Gly95Arg) |
- |
pathogenic (recessive) |
g.155269889C>T |
g.155300098C>T |
- |
- |
PKLR_000148 |
- |
PubMed: Bianchi 2020 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.283+24G>A |
- |
r.(?) |
p.? |
- |
likely benign |
g.155269865C>T |
g.155300074C>T |
- |
- |
PKLR_000415 |
- |
PubMed: Berghout 2012 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |